Skip to content

A controlled trial of automated delivery of three intravenous anesthetics using robotic anesthesia system for total intravenous anesthesia

A non-inferiority randomized controlled trial to evaluate the efficacy and safety of automated delivery of three anesthetics using a robotic anesthesia system for total intravenous anesthesia with propofol, remifentanil, and rocuronium - A non-inferiority randomized controlled trial of automated delivery of three intravenous anesthetics using a robotic anesthesia system for total intravenous anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032180067
Enrollment
60
Registered
2018-12-28
Start date
2019-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with ASA physical status 1-3, scheduled for surgery under total intravenous anesthesia.

Interventions

Manually controlled anesthesia (control group): Propofol, remifentanil and rocuronium are titrated manually by the attending anesthesiologist considering patient condition and surgical situation as us

Sponsors

Nagata Osamu
Lead Sponsor
Kenji Shigemi
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Male and female patients over 20 years old at the time of informed consent 2.Patients with ASA physical status of 1, 2, and 3 who are scheduled for surgery under general anesthesia 3.Patients who understand the contents of this study and are willing to provide written informed consent for participation in this study

Exclusion criteria

Exclusion criteria: 1.Patients with a history of hypersensitive to propofol, remifentanil, rocuronium or sugammadex. 2.Patients who are pregnant or lactating. 3.Patients who are determined not to be eligible for participation in this study by the research director.

Design outcomes

Primary

MeasureTime frame
Percentage of time during which an appropriate state of anesthesia was obtained within the operation time (before and after data cleaning). An appropriate state of anesthesia shall be satisfied when the following three conditions are satisfied; (1) Percentage of time that BIS is maintained within the target range (35-55) from start to end of surgery, (2) The number of incidences of hemodynamic changes (increase in pulse rate and blood pressure) observed from start to end of surgery except within 5 minutes after administration of inotrope, (3) Percentage of time that muscle relaxation is maintained within the target range (0% < T1 <= 10%) from start to end of surgery

Secondary

MeasureTime frame
1. Percentage of time that BIS is maintained within the target range (35-55) from start to end of surgery (before and after data cleaning) 2. The number of incidences of hemodynamic changes (increase in pulse rate and blood pressure) observed from start to end of surgery except within 5 minutes after administration of inotrope (before and after data cleaning) 3. Percentage of time that muscle relaxation is maintained within the target range (0% 55) from start to end of surgery (before and after data cleaning) 6. Average and median of BIS (before and after data cleaning) 7. Incidence of body movement (before and after data cleaning) 8. Average dosage of propofol per hour 9. Average dosage of remifentanil per hour 10. Average dosage of rocuronium per hour 11. Time from the end of rocuronium administration to the recovery of %T1 over 100% or of TOF ratio over 0.9 12. Anesthesia-related adverse events that occurred within 48 hours after surgery (incidence of PONV, shivering, delirium and percentage of patients who received additional analgesic agent)

Countries

Japan, Japan only

Contacts

Public ContactOsamu Nagata

Center Hospital of the National Center for Global Health and Medicine

onagata@hosp.ncgm.go.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026